Red blood cells from patients with type 2 diabetes mellitus induce vascular endothelial dysfunction via a mechanism involving vascular arginase I and reactive oxygen species
Inhibition of Interleukin-6 activity by tocilizumab improves arterial stiffness, LV myocardial deformation and endothelial glycocalyx in patients with rheumatoid arthritis.